news
Scientists use dead C. sporogenes bacteria to kill cancer cells
10 November 2015 | By Victoria White
In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74%...
List view / Grid view
Hit-to-Lead
news
Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
6 November 2015 | By SMi
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
news
Eisai and IPC enter oncology R&D collaboration
4 November 2015 | By Victoria White
IPC will perform chemo-informatic virtual screening of a pre-selected Eisai chemical library, to identify new protein-protein inhibitors for further biological evaluation...
news
Hercules receives Eurostars grant to develop CB7993113 for breast cancer
3 November 2015 | By Victoria White
Hercules has said that the Eurostars grant will enable the company to advance CB7993113 through preclinical development towards clinical trials in patients with triple negative breast cancer...
news
Merck and Selvita announce oncology drug discovery collaboration
3 November 2015 | By Victoria White
The aim of the collaboration is to deliver potential first-in-class small molecules as lead candidate drugs for multiple oncology indications...
news
Tumours may ‘seed’ cancer metastases earlier than expected
30 October 2015 | By Victoria White
The researchers said the findings highlight the urgent need for new methods to diagnose cancers early and new treatments to fight growing metastases...
news
MD Anderson’s expands its Moon Shots Programme
30 October 2015 | By Victoria White
MD Anderson's Moon Shots Programme is an unprecedented effort and novel organisational model designed to more rapidly convert scientific discoveries into life-saving advances...
news
Domainex expands its drug discovery service business
29 October 2015 | By Victoria White
Domainex is expanding all aspects of its drug discovery service business including biology, analytical chemistry and medicinal chemistry...
news
UCLA discovery could lead to better recovery after stroke
28 October 2015 | By Victoria White
Researchers have identified a molecule that, after a stroke, initiate repairs to the brain...
news
Chemical probe switches off two cancer-causing proteins
26 October 2015 | By Victoria White
The discovery sheds new light on the role these proteins play in driving cancer cell proliferation...
news
Study shows immunosuppressive effects of CA125 on farletuzumab
26 October 2015 | By Victoria White
The new findings have led to the hypothesis that patients with high levels of CA125 have an immunosuppressive tumour microenvironment that may potentially enable cancer cells to escape immune-mediated cytotoxicity...
news
Disease recreated in mini-kidney organoids in the lab
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
news
Gene discovery could lead to new treatments for sepsis
22 October 2015 | By Victoria White
Scientists have isolated the gene that produces Gasdermin-D - a protein that plays a critical role in the pathway to sepsis...
news
Launch of Dementia Discovery Fund to deliver new dementia treatments by 2025
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
news
Domainex and ICL team up to discover myocardial infarction therapies
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
